Monday, 16 November 2020

Moderna vaccine's effectiveness bodes well for Oxford/AstraZeneca jab

Phase 3 success rate of 95% for US firm’s treatment is promising for UK vaccine trial * Coronavirus – latest updates * See all our coronavirus coverage Hopes are rising for the Covid jab being developed by Oxford University, after Moderna became the second company to reveal impressive results from its vaccine trials. Interim results from phase 3 clinical trials of the Covid vaccine from US company Moderna has revealed it to be almost 95% effective at preventing the disease. The news followed an announcement last week from Germany-based Pfizer and BioNTech that their vaccine was more than 90% effective. Continue reading...
http://dlvr.it/Rlq35F
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

The Veterinarians Preventing the Next Pandemic

Skip to main content Open Navigation Menu Most new diseases have their origins in animals. So why aren’t we paying more attention to their h...